期刊文献+

热CO_2气腹处理后结肠癌细胞株COLO 205的蛋白组学变化 被引量:1

Proteomics Changes of Colonic Cancer Cell COLO 205 after Treatment with Hyperthermic CO_2 Pneumoperitoneum
原文传递
导出
摘要 目的:研究热CO_2气腹处理后结肠癌细胞株COLO 205的蛋白组学变化,为阐明热CO_2气腹对结肠癌细胞的杀伤作用机制提供依据。方法:用热CO_2气腹处理结肠癌细胞株COLO 205,按有无处理分为处理组与对照组。分别抽提两组细胞的总蛋白质,采用同位素标记的相对和绝对定量(isobaric tags for relative absolute quantitation,iTRAQ)技术标记,液相色谱(LC)分离蛋白质,质谱仪(MS)进行蛋白质鉴定及Western b1ot检测。结果:共筛选得到18个差异表达的蛋白,其中8个蛋白表达上调,10个蛋白表达下调。Western blot显示热休克蛋白HSP70在细胞表达明显高于对照组(P<0.01);蛋白Myosin-9的表达量在处理后显著下降。结论:热CO_2气腹处理后结肠癌细胞株COLO 205的蛋白组学发生差异性变化。 Objective: To study the proteomics changes of colonic cancer cell COLO 205 after treatment with hyperthermic COs pneumoperitoneum, and to define the mechanism of the cell-killing effect of it on the cells. Methods: The total protein of colonic cancer cell COLO 205 was extracted and labeled by isobaric tags for relative and absolute quantitation OTRAQ). The labeled proteins were isolated by liquid chromatography tandem mass spectrometry(LC-MS)on linear ion trap mass spectrometer in integrated mode comprising pulsed-Q-dissociation (PQD) to identify the differentially expressed proteins. The differentially expressed proteins were analyzed by Western blot. Results: Eighteen proteins were identified,among which 8 were highly expressed and 10 were lowly expressed after treatment by HT-CO2. Western blot showed that expression of HSP70 was increased and expression of Myosin-9 was decreased compared to the control group. Conclusion: The proteome profiles of colonic cancer cell COLO205 before and after treatment with HT-CO2 were differentially changed.
出处 《现代生物医学进展》 CAS 2011年第16期3009-3011,3016,共4页 Progress in Modern Biomedicine
基金 国家自然科学基金项目(30873000)
关键词 结肠癌 CO2气腹 同位素标记的相对和绝对定量技术 蛋白质组学 Colon cancer hyperthermia COs pneumoperitoneum Isobaric tags for relative and absolute quantitation Proteome
  • 相关文献

参考文献14

  • 1Knorr C, Reingruber B, Meyer T, et al. Peritoneal carcinomatosis of colorectal cancer: incidence, prognosis, and treatment modalities [J]. Int J Colorectal Dis, 2004, 19(3): 181-187.
  • 2Koppe MJ, Boerman OC, Oyen WJ, et al. Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies [J]. Ann Surg, 2006, 243(2): 212-222.
  • 3Glehen O, Mohamed F, Gilly FN. Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia [ J]. Lancet Oncol, 2004, 5 (4): 219-228.
  • 4Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patientswith peritoneal carcinomatosis of eolorectal cancer[J]. J Clin Oncol, 2003, 21(20): 3737-3743.
  • 5Glehen O, Kwiatkowski F, Sugarbaker PH, et al. Cytoreductive sUrgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study[J]. J Clin Oncol, 2004, 22(16): 3284-3292.
  • 6Yuanfei Peng, Minhua Zheng, Bo Feng, et al. Hyperthermic CO2 pneumoperitoneum induces apoptosis in human colon cancer cells through Bax-associated mitochondrial pathway[J]. Oncology reports, 2008, 190): 73-79.
  • 7Vorotnikova E,Ivkov R,Foreman A,et al. The magnitude and Time-dependence of the apoptotic response of normal and malignant cells subjected to ionizing radiation versus hyperthermia [J]. lni JRadiat Biol, 2006,82(8):549-559.
  • 8Hildebrandt B,Wust P,Ahlers O,et al. The cellular and molecular basis of hyperthermia [J]. Crit Rev Oneol Hematol, 2002, 43 (1): 33-56.
  • 9Trieb K, Gerth R, Windhager R, et al. Serum antibodies against heat shock protein 60 are elevated in patients with osteosarcoma [J]. Immunobiology, 2000, 201(3-4): 368-376.
  • 10Uozaki H, Ishida T, Kakiuchi C, et al. Expression of heat shock proteins in osteosarcoma and its relationship to prognosis[J]. Path Res Pract, 2000, 196(10): 665-673.

同被引文献11

  • 1肖德胜,李景和,文继舫,胡忠良,傅春燕.Western blot检测蛋白表达方法的改进[J].临床与实验病理学杂志,2003,19(2):210-211. 被引量:14
  • 2刘斌,王为,薛辉,等.Westemblot及分析[M]//司徒镇强,吴军正.细胞培养.西安:世界图书出版公司,2000:256-258.
  • 3林楓译.Westernblot 印迹法[M]//Sambrook J, Fritsch EF,Maniatis T.分子克隆实验指南.北京:科学出版社,1999:888-898.
  • 4Jungblut PR, Bumann D,Hass G,et al. Comparativeproteome analysis of Helicobocter pylori [J], Mol Mi-crobiol,2000,36(3) :710-725.
  • 5Zhang X,Dong N, Yin L,et al. Hepatitis B virus X pro-tein up-regulatessurviving expression in hepatoma tis-sues[J]. J Med Virol,2005 ,77(3) : 374-381.
  • 6Kaur P, Rizk NM, Ibrahim S,et al. iTRAQ-BasedQuantitative Protein Expression Profiling and MRMVerification of Markers in Type 2 Diabetes [J] , Pro-teome Res,2012,11(11):5 527-5 539.
  • 7Zhu M, Dai S,Zhu N, et al. Methyl jasmonate respon-sive proteins in Brassica napus guard cells revealed byiTRAQ-based quantitative proteomics [ J ]. ProteomeRes,2012,11 (7):3 728-3 742.
  • 8涂江龙,任惠民.重症肌无力血清中碳酸酐酶Ⅲ及其抗体的检测[J].中国临床神经科学,2008,16(1):6-10. 被引量:2
  • 9聂赣娟,周建华,李茂玉,张鹏飞,段朝军,李萃,易红,汤参娥,冯雪萍,彭芳,陈主初,肖志强.肺鳞癌患者与健康人血清的差异蛋白质组学研究[J].生物化学与生物物理进展,2008,35(3):349-355. 被引量:10
  • 10蒋滢,曹利,向时庆,姚宏,张波.唐氏综合征母体血清时间分辨荧光免疫筛查和产前诊断分析[J].重庆医学,2009,38(1):70-72. 被引量:10

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部